A Phase Ib/II clinical trial of DDFPe as a radiosensitizer in glioblastoma
Although small, this trial shows that DDFPe used as a radiosensitizer appears to be safe and may provide some survival benefit.
A Phase Ib/II clinical trial of DDFPe as a radiosensitizer in glioblastoma
TOLD MRI validation of reversal of tumor hypoxia in glioblastoma with a novel oxygen therapeutic
Reversal of Tumor hypoxia following intravenous delivery of DDFPe
Dynamic Oxygenation Measurements Using a Phosphorescent Coating Window Chamber Model
Radiosensitization of Hs-766T Pancreatic Tumor Xenografts in Mice Dosed with DDFPe
Radiosensitization of hypoxic tumor cells by DDFPe